GRITSTONE BIO INC (GRTS)
US39868T1051 - Common Stock
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gritstone bio, Inc. ("Gritstone" or the "Company") (NASDAQ: GRTS). Such...
Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)
-- Paper details vaccine design optimization process of Gritstone’s “off-the-shelf” or shared neoantigen vaccine platform, SLATE -- -- Discovery of a...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gritstone bio, Inc. ("Gritstone" or the "Company") (NASDAQ: GRTS). Such...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gritstone bio, Inc. ("Gritstone" or the "Company") (NASDAQ: GRTS). Such...
Why Are Health Insurance Stocks HUM, UNH, CI Down Today?
Health insurance stocks are falling Tuesday after the Biden Administration announced it won't increase Medicare Advantage rates for 2025.
Ubisoft Layoffs 2024: What to Know About the Latest Round of Ubisoft Job Cuts
Ubisoft layoffs were announced for 45 of the company's employees as it streamlines its global publishing and Asia-Pacific units.
GOEV Stock Alert: Canoo Announces Expansion Into Saudi Arabia
Canoo stock is falling on Tuesday even as GOEV investors in the EV company learn of its latest expansion into Saudi Arabia.
Why Is Gritstone Bio (GRTS) Stock Down 44% Today?
Gritstone Bio stock is falling on Tuesday after the biotechnology company priced an underwritten public offering for GRTS shares.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to check out all of the biggest pre-market stock movers worth watching on with the winners and losers of Tuesday!
Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
EMERYVILLE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the...
Gritstone bio Announces Proposed Public Offering
EMERYVILLE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the...
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite
-- Early progression-free survival (PFS) trends favor GRANITE recipients with hazard ratios of 0.82 in the overall population ([95% CI, 0.34-1.67]; 62%...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gritstone bio, Inc. ("Gritstone" or the "Company") (NASDAQ: GRTS). Such...
3 Speculative Stocks You Can Buy for $3 or Less
Although speculative stocks below $3 aren’t for everyone, these small-cap enterprises could potentially pull off some surprises.
GRTS Stock Earnings: Gritstone Bio Beats EPS, Beats Revenue for Q4 2023
GRTS stock results show that Gritstone Bio beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
GRTS Stock Earnings: Gritstone Bio Beats EPS, Beats Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gritstone Bio (NASDAQ:GRTS) just reported results for the fourth quarter of 202...
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
-- Preliminary data from Phase 2 portion of Phase 2/3 study evaluating GRANITE, Gritstone’s personalized cancer vaccine in front-line metastatic,...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gritstone bio, Inc. ("Gritstone" or the "Company") (NASDAQ: GRTS). Such...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking on Friday as investors prepare for the last day of trading this week with all of the latest news!
Gritstone to cut 40% of staff due to funding delay, stock plunges 23% (NASDAQ:GRTS)
Gritstone bio (GRTS) shares plunged 23% in after-hours trading Thursday after the company disclosed it was slashing 40% of its workforce due to a funding delay. Read more here.
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
EMERYVILLE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the...
Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial
EMERYVILLE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the...